imiquimod has been researched along with methylprednisolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brunetti, G; Cozzi, R; Lo Schiavo, A; Puca, RV; Ruocco, E; Sangiuliano, S | 1 |
Bilgiç, B; Bostan, AB; Cebeci Kahraman, F; Karadağ, AS; Koska, MC; Özkan, K | 1 |
3 other study(ies) available for imiquimod and methylprednisolone
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Methylprednisolone; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pemphigus; Prednisone; Risk Assessment; Treatment Outcome; Vulvar Diseases | 2008 |
Infantile digital fibromatosis successfully treated with topical imiquimod 5% combined with methylprednisolone aceponate 0.1.
Topics: Administration, Topical; Fibroma; Humans; Imiquimod; Methylprednisolone | 2020 |